News

Trained immunity in alveolar macrophages can lead to damaging lung inflammation, confirming the importance of context in this phenomenon.
Cancer treatment has long faced a challenging trade-off: therapies strong enough to eliminate tumors often cause severe side ...
Lung cancer is Australia’s fifth most diagnosed cancer, but causes the greatest number of deaths because it is often ...
Raipur: A multidisciplinary team at the All India Institute of Medical Sciences (AIIMS) Raipur successfully removed a sharp ...
Results come after positive results from a trial among people with idiopathic pulmomary disease.
ASTRAZENECA is in talks with Summit Therapeutics to license an experimental lung-cancer drug under a deal worth as much as $15 billion, Bloomberg News reported on Thursday, citing people familiar with ...
Dr Anna Moore and Catherine Furlong explain how singing can improve lung health for people with chronic respiratory disease ...
AstraZeneca AZN announced that the European Commission has approved its blockbuster cancer drug, Imfinzi (durvalumab), for a ...
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...
BrightSpring Health Services Inc. (NASDAQ:BTSG) is a home and community-based healthcare services platform in the US that ...
Northwestern scientists have developed iSeg, a 3D AI tool that detects and tracks lung tumors on CT scans, even as they move ...